Multi-center trial of ziprasidone (Geodon) augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 08 Sep 2006
At a glance
- Drugs Ziprasidone (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 08 Sep 2006 The expected completion date for this trial is now 14 Mar 2004.
- 08 Sep 2006 New trial record.